FDA Investigator Sean D Duke
Sean D Duke has conducted inspections on 285 sites in 4 countries as of 14 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
285
Last Inspection Date:
14 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Argentina,
Taiwan,
Belize
FDA Investigators that have inspected at least one site in common with Sean D Duke:
Abdellah El Hajjam,
Addie V Scott Boston,
Alan D Centi,
Albert A Salvador,
Alexandra B Pitkin,
Andrew J Molesky,
Anita R Michael,
Ann Marie Karnick,
Anne E Johnson,
Anthony M Criscuolo, Jr,
Audrey Thereset Uy,
Brandi L Garbutt,
Brandon J Brookens,
Brian D Young,
Brian S Keefer,
Calvin W Edwards,
Cara M Minelli,
Carol A Perry,
Carol A Robles,
Cary Greene,
Cathleen A Carr Sharpe,
CDR Michael J Mero,
Celena Ngo,
Celia L Hutchinstein,
Chamberlain,
Christopher R Richardson,
Chyla T Hunter,
Crayton Lee,
Crystal A Harlan,
Cynthia White,
Daniel W Johnson,
Darlene C Plank Turlington,
Darrin E Davis,
Dauksism,
David L Pearce,
Dawn D Aiello,
Deborah G Haney Cozzone,
Deborah H Cozzone,
Debra J Bennett,
Dennis L Doupnik,
Derek S Dealy,
Devon Jenkins,
Donald W Myrick,
Doretha M Wilson,
Dr. Mark J Seaton, PhD,
Dung N Tran,
Edward D Mcdonald,
Edward O'shaughnessy,
Edward P Potter,
Edwin L Hobbs,
Eric S Myskowski,
Erik A Bungo,
Erika M Wilkerson,
Esaw,
Gale L Glinecki,
Gayle S Lawson,
Gerald W Kopp,
Gillian B Nardelli,
Giovanni A Vigilante,
Gregory E Beichner,
Jacqueline Johnson,
Jacquelyn Gess,
James M Odonnell,
James P Mcevoy,
James P Stallings,
Janaye A Young,
Jason M Sluzynski,
Jeen S Min,
Jessica D Nanini,
Jessica D Weber,
Jessica M Monteiro,
John C Su,
John Dan,
Johnson,
Joseph C Francisco,
Joseph L Despins, PhD,
Joseph S Fanelli,
Joseph T Dougherty,
Joshua C Schafer,
Judith A Jones,
Judith A Paterson,
Judy C Nepsa,
Julianne C Mccullough,
Justin B Holder,
Karen A Spencer,
Katelyn Astaub Zamperini,
Keith M Reilly,
Kelly N Kerr,
Kim G Campbell,
Kimberly A Dux,
Kish Bolden,
Kristen D Evans,
Kristina J Donohue,
Kyle D Covill,
Kyle S Hobson,
LCDR Margaret Edi Gennaro,
LCDR Susan E Polifko,
Linda M Hoover,
Linda M Ross,
LT John M Mastalski,
LTJG Bradley E Benasutti,
LTJG Lauren N Shade,
Marc A Jackson, Jr,
Margo C Jones,
Martha Sullivan Myrick,
Matthew R Noonan,
Maureen A Wentzel,
Melissa B Libby,
Melissa M Dauksis,
Melissa M Schafer,
Meredith L Sheridan,
Michael A Taylor,
Michael D Omeara,
Michael Rosner,
Michael S Call,
Michele M Falchek,
Mildred L Mccray,
Mohamad A Chahine,
Monique Rac Lester,
Myrick,
Nicholas J Lahey,
Nicole J Clausen,
Nikisha M Bolden,
O'meara,
Osama M Hamoud,
Pamela M Tremarki,
Ramanda C Gregory,
Raymond L Cheung,
Rina Bhikha,
Robert B Shibuya, MD,
Robert P Neligan,
Robert W Calais,
Ronald T Colucci,
Russell P Vandermark,
Ruth A Oni,
Sarah K Lemin,
Seng Ching Hwang,
Stephanie Mangigian, MS/OSH, RN,
Tamara N Champion,
Tammy L Chavis,
Tammy M Phillips,
Tegan M Vanartsdalen,
Teigan M Mule,
Thomas E Friel,
Timothy J Schmidt,
Todd J Maushart,
Tonya O Corbin,
Travell D Sawyer,
Valerie C Reed,
Valerie G Vallely,
Van Cliff,
Vlada Matusovsky,
Whitney S Reynolds,
William A Warnick,
William C Brenneman,
William D Murray,
Xinyi Hui,
Yessika Mashinski
Sean D Duke's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more